The healthcare industry is undergoing a transformative shift, moving from fee-for-service models to value-based care (VBC). This change emphasizes quality, patient outcomes, and cost-efficiency, demanding deeper insights into market trends, patient behaviors, and emerging therapies. Healthcare market research companies play a pivotal role in equipping pharmaceutical companies, healthcare providers, and investors with data-driven strategies to succeed in this evolving landscape. In this article, we explore the top 10 healthcare market research companies that are driving value-based care.
IQVIA stands as a global leader in healthcare data analytics, offering integrated solutions that span real-world evidence, clinical trials, and advanced analytics. Leveraging a vast database of patient-level information and sophisticated AI tools, IQVIA helps organizations predict market trends, optimize clinical trial designs, and improve patient engagement. Its expertise in VBC includes evaluating outcomes-based agreements, monitoring patient adherence, and measuring the economic impact of therapies. IQVIA’s solutions empower pharmaceutical executives and healthcare providers to make informed decisions in a rapidly shifting market.
Frost & Sullivan is renowned for its strategic market intelligence and consulting services across healthcare sectors. The company’s research encompasses biotechnology, pharmaceuticals, digital health, and medical devices, offering comprehensive market forecasts and growth strategies. Frost & Sullivan excels in value-based care by assessing performance metrics, regulatory impacts, and innovative payment models. Its deep-dive reports enable healthcare organizations and investors to identify emerging opportunities and align strategies with patient-centered care objectives.
Kantar Health provides global market research and consulting services specifically tailored to the healthcare and pharmaceutical sectors. By integrating qualitative and quantitative research methodologies, Kantar Health delivers insights into patient needs, market access, and therapy adoption. The company’s focus on outcomes-based research supports value-based care initiatives by evaluating treatment effectiveness, patient satisfaction, and healthcare utilization trends. Pharmaceutical companies rely on Kantar Health to design market strategies that maximize impact while improving health outcomes.
DelveInsight is a prominent market research and consulting firm that specializes in healthcare, biotech, and pharmaceutical intelligence. The company provides detailed reports, pipeline analyses, and disease-specific research that guide strategic decision-making in value-based care. DelveInsight’s offerings include epidemiology forecasts, competitive landscape assessments, and commercial opportunity analyses. By delivering precise and actionable insights, the firm helps healthcare organizations, pharma companies, and investors optimize resource allocation, improve patient outcomes, and navigate the complexities of outcomes-driven payment models.
GlobalData Healthcare offers an extensive suite of research services including market intelligence, competitive benchmarking, and trend analysis across pharmaceuticals, biotechnology, and medical devices. The company’s insights support value-based care by identifying cost-effective therapies, evaluating patient outcomes, and assessing payer strategies. GlobalData’s actionable intelligence aids executives and investors in making data-backed decisions to enhance care quality and financial performance in a healthcare environment increasingly focused on value.
While IQVIA dominates global analytics, other specialized research companies provide niche insights critical to value-based care. Firms like Decision Resources Group (DRG) and EvaluatePharma focus on therapy-specific pipelines, market access, and payer strategies. Their research enables pharmaceutical companies to structure outcome-based contracts, understand competitive dynamics, and optimize launch strategies. By providing granular intelligence, these companies facilitate data-driven approaches that align with patient-centric care models.
McKinsey’s Healthcare Practice combines consulting expertise with market research capabilities to drive transformation in the healthcare sector. The firm offers data-driven insights on care delivery optimization, digital health adoption, and value-based payment models. By analyzing operational efficiency, patient outcomes, and cost structures, McKinsey supports healthcare providers and payers in implementing successful VBC initiatives. Their strategic guidance enables stakeholders to improve population health management while maintaining financial sustainability.
Navigant Consulting, now integrated into Guidehouse, delivers specialized healthcare advisory and market research services. Its offerings include performance improvement, regulatory analysis, and payer-provider insights. Navigant supports value-based care initiatives by helping organizations measure outcomes, implement innovative payment models, and enhance clinical efficiency. By combining research with actionable recommendations, the company ensures healthcare stakeholders can adapt to the evolving VBC landscape while mitigating financial and operational risks.
Global Market Insights provides comprehensive market research reports and consulting services across healthcare, pharmaceuticals, and medical devices. Its expertise includes market sizing, competitive analysis, and growth forecasting. GMI contributes to value-based care by identifying trends in patient outcomes, therapy adoption, and healthcare spending. Investors and healthcare executives use GMI’s research to make informed decisions about portfolio allocation, strategic partnerships, and market entry strategies in a results-driven healthcare environment.
CB Insights leverages AI-driven analytics to provide insights into emerging healthcare technologies, startup innovations, and investment trends. Its platform enables real-time monitoring of market developments, M&A activity, and venture capital investments in the healthcare space. By highlighting disruptive solutions and innovative care models, CB Insights supports value-based care initiatives by helping organizations identify new approaches to improve outcomes, reduce costs, and enhance patient experiences. Its forward-looking intelligence equips decision-makers with actionable insights for strategic planning.
As the healthcare industry pivots toward value-based care, market research has never been more critical. Companies such as IQVIA, Frost & Sullivan, Kantar Health, DelveInsight, and others are providing the analytical frameworks and insights necessary for stakeholders to thrive in this outcomes-focused landscape. By leveraging these research leaders, pharmaceutical companies, healthcare providers, and investors can optimize resource allocation, improve patient outcomes, and make strategic decisions backed by data.
Understanding market dynamics, patient needs, and competitive landscapes is essential to achieving success in a healthcare ecosystem increasingly defined by value. Engaging with top-tier market research firms enables organizations to stay ahead of trends, anticipate challenges, and capitalize on opportunities, ultimately driving sustainable growth and better healthcare delivery for patients worldwide.